The Evidence behind Inhibitor Treatment with Porcine Factor VIII

Publisher： Karger

E-ISSN： 1424-8840|32|1|5-8

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.32, Iss.1, 2002-05, pp. : 5-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Evidence behind Inhibitor Treatment with Recombinant Factor VIIa

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 1, 2002-05 ,pp. : 13-18

Karger

Access to resources Recommend Favorite

Antibodies against Factor VIII in Patients with Solid Tumors: Successful Treatment of Cancer May Suppress Inhibitor Formation

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 5, 1999-07 ,pp. : 244-249

Karger

Access to resources Recommend Favorite

Acquired Inhibitor to Factor VIII in a Nonhemophiliac Patient

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 34, Iss. 6, 1986-06 ,pp. : 472-474

John Wiley & Sons Inc

Access to resources Recommend Favorite

Recombinant porcine factor VIII: a new instalment of a long story

By  

HAEMOPHILIA, Vol. 21, Iss. 2, 2015-03 ,pp. : 149-151

John Wiley & Sons Inc

Access to resources Recommend Favorite

Half‐life extended factor VIII for the treatment of hemophilia A

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. S1, 2015-06 ,pp. : S176-S179

John Wiley & Sons Inc

Access to resources Recommend Favorite